Nuclivision develops software solutions, including Nuclarity, designed to enhance nuclear medicine workflows. This technology aims to make nuclear medicine procedures faster, safer for patients, and more accessible. The software delivers enhanced PET images, improving patient safety and streamlining operations within imaging centers.
Funding
$430K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current PET imaging workflows often involve long wait times, high costs due to expensive radiotracer doses, and potential risks associated with radioactive exposure for oncology patients. These challenges can hinder timely diagnosis and treatment.
Solution
Nuclivision offers software solutions designed to enhance PET imaging, focusing on improving image quality while reducing radiation exposure and optimizing workflows. Their flagship product, Nuclarity, leverages AI to deliver enhanced PET images, boosting patient safety and streamlining operations for more efficient imaging centers. By optimizing image acquisition and processing, Nuclarity assists physicians throughout the entire workflow, from initial scan to diagnosis and follow-up, ultimately tackling the challenges of growing demands, radioactive exposure, and high costs in nuclear medicine.
Target Audience
The primary target audience includes physicians, nuclear medicine professionals, and hospitals seeking to improve PET imaging workflows, enhance patient safety, and reduce costs.
Features
- AI-driven PET image enhancement to improve image quality
- Reduction of radioactive tracer dose during scans
- Streamlined workflows for more efficient imaging centers
- Assistance for physicians throughout the entire imaging workflow, from acquisition to diagnosis and follow-up